BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Chinese Patent Office
Harvard Business School
Cantor Fitzgerald
US Department of Justice
Johnson and Johnson
Teva
Chubb
Federal Trade Commission

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,096,885

« Back to Dashboard

Summary for Patent: 5,096,885
Title: Human growth hormone formulation
Abstract:A stable pharmaceutically acceptable formulation containing human growth hormone, glycine, mannitol, a buffer, and optionally, a non-ionic surfactant is disclosed. The formulation contains human growth-hormone: glycine in 1:50-200 molar ratios. Also disclosed are associated means and methods for preparing and using such formulations.
Inventor(s): Pearlman; Rodney (El Granada, CA), Oeswein; James Q. (Montara, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Application Number:07/182,262
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Dosage form; Device;

Drugs Protected by US Patent 5,096,885

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,096,885

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 112685 ➤ Subscribe
Austria 197405 ➤ Subscribe
Austria 359824 ➤ Subscribe
Australia 3368789 ➤ Subscribe
Australia 4792793 ➤ Subscribe
Australia 627174 ➤ Subscribe
Australia 686567 ➤ Subscribe
Canada 1329543 ➤ Subscribe
Canada 2139358 ➤ Subscribe
Canada 2337745 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Julphar
Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission
Novartis
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot